TAURX THERAPEUTICS LTD.

ACTIVE

3 Shenton Way, Singaporetaurx.comPrivate501–1,000 employeesEstablished: 2002-01-01

Clinical Trials

35 active

Approvals

Total approvals

Agencies

Regulatory bodies

Founded

2002

Overview

Trial Phase Distribution

Phase

Trials

Phase 1

62.0%

Phase 3

16.0%

Phase 2

6.0%

Trial Status Distribution

Active, not recruiting

70.0%

Available

2.0%

Completed

22.0%

Recruiting

2.0%

Terminated

4.0%

Clinical Trials

Trials sponsored by this organization (50)

A comparison study of TRx0237 (LMTM) and placebo in patients with early Alzheimer's Disease.

Phase 1

Active, not recruiting

Jan 2021375 participants

A comparison study of TRx0237 (LMTM) and placebo in patients with early Alzheimer's Disease.

Phase 1

Active, not recruiting

Jan 2019375 participants

A comparison study of TRx0237 (LMTM) and placebo in patients with Alzheimer's Disease.

Phase 1

Active, not recruiting

Mar 2018450 participants

A comparison study of TRx0237 (LMTM) and placebo in patients with Alzheimer's Disease.

Phase 1

Active, not recruiting

Dec 2017450 participants

Safety and Efficacy of TRx0237 in Subjects With Alzheimer's Disease Followed by Open-Label Treatment

Phase 3

Completed

interventional

Dec 2017598 participants

A comparison study of TRx0237 (LMTM) and placebo in patients with Alzheimer's Disease.

Phase 1

Active, not recruiting

Nov 2017500 participants

An open-label extension study evaluating the safety and tolerability of leuco-methylthioninium dihydromesylate (LMTM) in subjects with Alzheimer's Disease or a rare form of dementia (Behavioral Variant Frontotemporal Dementia) who have completed an earlier Phase trial

Phase 1

Active, not recruiting

Jul 2015966 participants

An open-label extension study evaluating the safety and tolerability of leuco-methylthioninium dihydromesylate (LMTM) in subjects with Alzheimer's Disease or a rare form of dementia (Behavioral Variant Frontotemporal Dementia) who have completed an earlier Phase trial

Phase 1

Active, not recruiting

Mar 2015966 participants

Page 1 of 7

Approvals

No approval data available

News

No news articles found

Back to Organizations